Expertise in
15
conditions

Dr. Jashmin Patel

Oncology
St. Luke's Regional Medical Center LTD
100 E Idaho St, 
Boise, ID 
Offers Telehealth
Expertise in
15
conditions
St. Luke's Regional Medical Center LTD
100 E Idaho St, 
Boise, ID 

Overview

Jashmin Patel is an Oncologist practicing medicine in Boise, Idaho.

Dr. Patel is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pancreatic Cancer, and Familial Pancreatic Cancer.

She is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 4 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in ID

Hospital Affiliations

St Luke's Elmore Medical Center
St Luke's Nampa Medical Center
St Luke's Regional Medical Center
St Luke's Wood River Medical Center
St Luke's Mccall

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

St. Luke's Regional Medical Center LTD
100 E Idaho St, Boise, ID 83712
Other Locations
St. Luke's Regional Medical Center
190 E Bannock St, Boise, ID 83712

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: April 14, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: February 18, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy.
A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy.
Journal: SpringerPlus
Published: February 27, 2015
Similar Doctors
Expertise in
15
conditions
Dr. Gerardo Perez
Oncology
Expertise in
15
conditions
Dr. Gerardo Perez
Oncology

St. Luke's Regional Medical Center

190 E Bannock St, 
Boise, ID 
 (0.6 miles away)
208-381-4171
Languages Spoken:
English
See accepted insurances

Gerardo Perez is an Oncologist practicing medicine in Boise, Idaho. Dr. Perez is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Oophorectomy.

Expertise in
14
conditions
Dr. G Connor
Oncology
Expertise in
14
conditions
Dr. G Connor
Oncology

Saint Alphonsus Boise-Gynecologic Oncology

900 N Liberty St Ste 101, 
Boise, ID 
 (4.6 miles away)
208-367-5050
Languages Spoken:
English
See accepted insurances

G Connor is an Oncologist practicing medicine in Boise, Idaho. Dr. Connor is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy.

Expertise in
49
conditions
Dr. Jonathan Swerdloff
Oncology
Expertise in
49
conditions
Dr. Jonathan Swerdloff
Oncology

Office

308 E Hawaii Ave, 
Nampa, ID 
 (19.2 miles away)
208-467-6700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonathan Swerdloff is an Oncologist practicing medicine in Nampa, Idaho. Dr. Swerdloff is highly rated in 49 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Paget Disease of the Breast.

Frequently Asked Questions about Dr. Jashmin Patel

How do I make an appointment with Dr. Jashmin Patel?

You can book an appointment with Dr. Jashmin Patel by calling their office at 208-381-2711. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jashmin Patel a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jashmin Patel is classified as an Advanced expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jashmin Patel specialize in?

While Dr. Jashmin Patel is a Oncology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Jashmin Patel participate in research or clinical trials?

Yes. Dr. Jashmin Patel has published 2 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Jashmin Patel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jashmin Patel accept my insurance?

Dr. Jashmin Patel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 208-381-2711 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
      View All 15 Advanced Conditions
      View All 72 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile